A novel unbalanced whole-arm translocation der(3;10)(q10;q10) in acute monocytic leukemia

Cancer Genetics and Cytogenetics

Volumn 199, Issue 2, 2010, Pages 134-138

  Yamamoto, Katsuya ^a   Okamura, Atsuo ^a   Wakahashi, Kanako ^a   Katayama, Yoshio ^a   Shimoyama, Manabu ^a   Matsui, Toshimitsu ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 NAPHTHYL BUTYRATE ESTERASE; CD33 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CELL SURFACE MARKER; ESTERASE; HEMOGLOBIN; HLA DR ANTIGEN; MICROSOMAL AMINOPEPTIDASE; MYELOPEROXIDASE; UNCLASSIFIED DRUG;

ACUTE MONOCYTIC LEUKEMIA; ADULT; ARTICLE; BONE MARROW CELL; CANCER INFILTRATION; CASE REPORT; CHROMOSOME 10P; CHROMOSOME 3; CHROMOSOME 3Q; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; MALE; MONOCYTE MACROPHAGE PRECURSOR CELL; PATHOGENESIS; PRIORITY JOURNAL; SPECTRAL KARYOTYPING; STRUCTURAL CHROMOSOME ABERRATION; THROMBOCYTE COUNT;

BONE MARROW; CHROMOSOMES, HUMAN, PAIR 10; CHROMOSOMES, HUMAN, PAIR 3; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA, MONOCYTIC, ACUTE; MALE; MIDDLE AGED; TRANSLOCATION, GENETIC;

EID: 77952750130     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2010.02.006     Document Type: Article

References (23)

1. Arber D.A., Brunning R.D., Orazi A., Porwit A., Peterson L., Thiele J., Le Beau M.M. Acute myeloid leukaemia, not otherwise specified. WHO classification of tumours of haematopoietic and lymphoid tissues 2008, 130-139. World Health Organization; Lyon: IARC Press, Geneva. 4th ed. S.H. Swerdlow, E. Campo, N.L. Harris, E.S. Jaffe, S.A. Pileri, H. Stein, J. Thiele, J.W. Vardiman (Eds.).
2. Adeyinka A., Wei S., Sanchez J. Loss of 17p is a major consequence of whole-arm chromosome translocations in hematologic malignancies. Cancer Genet Cytogenet 2007, 173:136-143.
3. Sanada M., Uike N., Ohyashiki K., Ozawa K., Lili W., Hangaishi A., Kanda Y., Chiba S., Kurokawa M., Omine M., Mitani K., Ogawa S. Unbalanced translocation der(1;7)(q10;p10) defines a unique clinicopathological subgroup of myeloid neoplasms. Leukemia 2007, 21:992-997.
4. Johansson B., Arheden K., Höglund M., Othzén A., Békássy A.N., Turesson I., Heim S., Mitelman F. Fluorescence in situ hybridization analysis of whole-arm 7;12 translocations in hematologic malignancies. Genes Chromosomes Cancer 1995, 14:56-62.
5. Bacher U., Haferlach T., Schoch C. Gain of 9p due to an unbalanced rearrangement der(9;18): a recurrent clonal abnormality in chronic myeloproliferative disorders. Cancer Genet Cytogenet 2005, 160:179-183.
6. ISCN 2009: an international system for human cytogenetic nomenclature (2009) 2009, S. Karger, Basel. L.G. Schaffer, M.L. Slovak, L.J. Campbell (Eds.).
7. Mitelman F, Johansson B, Mertens F, editors. Mitelman database of chromosome aberrations in cancer [Internet]. Updated November 16, 2009. Accessed December 18, 2009. Available at http://cgap.nci.nih.gov/Chromosomes/Mitelman.
8. Pedersen B., Nørgaard J.M., Pedersen B.B., Clausen N., Rasmussen I.H., Thorling K. Many unbalanced translocations show duplication of a translocation participant: clinical and cytogenetic implications in myeloid hematologic malignancies. Am J Hematol 2000, 64:161-169.
9. Yamamoto K., Okamura A., Katayama Y., Shimoyama M., Matsui T. Unbalanced whole-arm translocation der(5;19)(p10;q10) is a novel and recurrent cytogenetic aberration in myelodysplastic syndrome. Leuk Res 2009, 33:377-383.
10. Arber D.A., Brunning R.D., Orazi A., Bain B.J., Porwit A., Vardiman J.W., Le Beau M.M., Greenberg P.L. Acute myeloid leukaemia with myelodysplasia-related changes. WHO classification of tumours of haematopoietic and lymphoid tissues 2008, 124-126. World Health Organization; Lyon: IARC Press, Geneva. 4th ed. S.H. Swerdlow, E. Campo, N.L. Harris, E.S. Jaffe, S.A. Pileri, H. Stein, J. Thiele, J.W. Vardiman (Eds.).
11. Davidsson J., Heidenblad M., Bong Å., Johansson B. Array-based comparative genomic hybridization of cytogenetically polyclonal myeloid malignancies. Cancer Genet Cytogenet 2006, 169:179-180.
12. Westbrook C.A., Hsu W.T., Chyna B., Litvak D., Raza A., Horrigan S.K. Cytogenetic and molecular diagnosis of chromosome 5 deletions in myelodysplasia. Br J Haematol 2000, 110:847-855.
13. Side L.E., Curtiss N.P., Teel K., Kratz C., Wang P.W., Larson R.A., Le Beau M.M., Shannon K.M. RAS, FLT3, and TP53 mutations in therapy-related myeloid malignancies with abnormalities of chromosomes 5 and 7. Genes Chromosomes Cancer 2004, 39:217-223.
14. Zhao L, Hayes K, Khan Z, Glassman A. Spectral karyotyping study of chromosome abnormalities in human leukemia [Erratum in: Cancer Genet Cytogenet 2001;131:94-95]. Cancer Genet Cytogenet 2001;127:143-7.
15. Göhring G., Karow A., Steinemann D., Wilkens L., Lichter P., Zeidler C., Niemeyer C., Welte K., Schlegelberger B. Chromosomal aberrations in congenital bone marrow failure disorders-an early indicator for leukemogenesis?. Ann Hematol 2007, 86:733-739.
16. Van Limbergen H., Poppe B., Michaux L., Herens C., Brown J., Noens L., Berneman Z., De Bock R., De Paepe A., Speleman F. Identification of cytogenetic subclasses and recurring chromosomal aberrations in AML and MDS with complex karyotypes using M-FISH. Genes Chromosomes Cancer 2002, 33:60-72.
17. Lessard M., Hélias C., Struski S., Perrusson N., Uettwiller F., Mozziconacci M.J., Lafage-Pochitaloff M., Dastugue N., Terré C., Brizard F., Cornillet-Lefebvre P., Mugneret F., Barin C., Herry A., Luquet I., Desangles F., Michaux L., Verellen-Dumoulin C., Perrot C., Van de Akker J., Lespinasse J., Eclache V., Berger R. Groupe Francophone de Cytogénétique Hématologique (GFCH). Fluorescence in situ hybridization analysis of 110 hematopoietic disorders with chromosome 5 abnormalities: do de novo and therapy-related myelodysplastic syndrome-acute myeloid leukemia actually differ?. Cancer Genet Cytogenet 2007, 176:1-21.
18. Huret J.L., Brizard A., Slater R., Charrin C., Bertheas M.F., Guilhot F., Hählen K., Kroes W., van Leeuwen E., Schoot E.V., Beishuizen A., Tanzer J., Hagemeijer A. Cytogenetic heterogeneity in t(11;19) acute leukemia: clinical, hematological and cytogenetic analyses of 48 patients-updated published cases and 16 new observations. Leukemia 1993, 7:152-160.
19. Dierlamm J., Michaux L., Wlodarska I., Pittaluga S., Zeller W., Stul M., Criel A., Thomas J., Boogaerts M., Delaere P., Cassiman J.J., De Wolf-Peeters C., Mecucci C., Van den Berghe H. Trisomy 3 in marginal zone B-cell lymphoma: a study based on cytogenetic analysis and fluorescence in situ hybridization. Br J Haematol 1996, 93:242-249.
20. Gazzo S., Baseggio L., Coignet L., Poncet C., Morel D., Coiffier B., Felman P., Berger F., Salles G., Callet-Bauchu E. Cytogenetic and molecular delineation of a region of chromosome 3q commonly gained in marginal zone B-cell lymphoma. Haematologica 2003, 88:31-38.
21. Wong K.F., So C.C., Chan J.C.W., Kho B.C.S., Chan J.K.C. Gain of chromosome 3/3q in B-cell chronic lymphoproliferative disorder is associated with plasmacytoid differentiation with or without IgM overproduction. Cancer Genet Cytogenet 2002, 136:82-85.
22. Haltrich I., Kost-Alimova M., Kovács G., Klein G., Fekete G., Imreh S. Multipoint interphase FISH analysis of chromosome 3 abnormalities in 28 childhood AML patients. Eur J Haematol 2006, 76:124-133.
23. Tosi S., Mosna G., Cazzaniga G., Giudici G., Kearney L., Biondi A., Privitera E. Unbalanced t(3;12) in a case of juvenile myelomonocytic leukemia (JMML) results in partial trisomy of 3q as defined by FISH. Leukemia 1997, 11:1465-1468.